Syngenta Media Releases:

Syngenta receives approval for new corn technologies in Argentina

Basel, Switzerland, December 22, 2009

• Stacked trait approval broadens offer to Argentine growers
• Reinforces Syngenta corn offer in Argentina

Syngenta announced today that it has received cultivation approval for its genetically modified corn trait Bt11xGA21 from the Ministry of Agriculture in Argentina. Bt11xGA21 is a double-stacked corn trait combining insect resistance and herbicide tolerance in a single product. The product will be available to Argentine growers for the 2010/2011 season.

Davor Pisk, Chief Operating Officer Syngenta Seeds, said: “We are pleased to receive this approval, which underlines the ongoing support for modern agricultural technology in Argentina. Syngenta already has a strong position in corn in Argentina and this approval will further strengthen our offer in the country, while bringing growers higher value and more convenience.”

Bt11xGA21 stacked corn is approved for cultivation in the United States, Canada and since November in Brazil.

PDF version

Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com or www.growmorefromless.com.

Syngenta Analyst / Investor Enquiries:

Jennifer Gough	Switzerland	+41 61 323 5059
	USA	+1 202 737 6521
John Hudson	Switzerland	+41 61 323 6793
	USA	+1 202 737 6520

Syngenta Media Enquiries:

Médard Schoenmaeckers

Switzerland

+41 61 323 2323

Syngenta Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.